Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases.
Dandu, Reddeppareddy; Zulli, Allison L; Bacon, Edward R; Underiner, Ted; Robinson, Candy; Chang, Hong; Miknyoczki, Sheila; Grobelny, Jennifer; Ruggeri, Bruce A; Yang, Shi; Albom, Mark S; Angeles, Thelma S; Aimone, Lisa D; Hudkins, Robert L.
Bioorg Med Chem Lett
; 18(6): 1916-21, 2008 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-18308565
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.
IAP antagonization promotes inflammatory destruction of vascular endothelium.
Evaluation of Novel Chalcone Oximes as Inhibitors of Tyrosinase and Melanin Formation in B16 Cells.
Loss of IFN-Î³ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
Mitotic progression following DNA damage enables pattern recognition within micronuclei.
Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization.
<sup>99m</sup> Tc-labeled NGR-chlorambucil conjugate, <sup>99m</sup> Tc-HYNIC-CLB-c(NGR) for targeted chemotherapy and molecular imaging.
Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.
4-n-butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells.